• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthpublic health

Stop Freaking Out About That Study Linking Diet Soda to Alzheimer’s and Strokes

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
April 24, 2017, 10:24 AM ET

You may have come across some pretty alarming takes on diet soda going into this past weekend. “Daily dose of diet soda tied to triple risk of deadly stroke,” blared Fox News. Outlets like the Washington Post and CNN repeated the assertion that drinking artificially sweetened beverages may increase the risk that your brain just maybe headed for a blood clot or serious mental deterioration because you like to drink Diet Coke. Don’t believe the hype; the situation probably isn’t nearly as dire as that.

Some of the reports about this “deadly diet soda” study have been more nuanced than others. But there’s a common theme among a lot of them—they don’t outline some of its most crucial and relevant caveats until way past the headline. And if they did, the titles would be pretty boring. Like, “Study determines minor observational link (but no direct cause-and-effect) between certain people who drink artificial sugar beverages, but it has a small sample size that doesn’t include minorities or account for a whole bunch of other critical factors.”

Click here to subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

That’s not exactly as sexy as claiming that a Diet Coke a day will bring Alzheimer’s in its wake, or triple the chances of a stroke. But science, fortunately (or unfortunately if you’re trying to grab clicks at the expense of good information), isn’t meant to be sexy. It’s meant to test hypotheses and express facts. And when the results of scientific experiments are presented without context, they lead to misleading, panicky headlines like the ones that dominated the Internet on Friday.

Physician Aaron Carroll, who writes for one of the most clear-eyed, if wonky, health care websites out there—the Incidental Economist—and has a delightfully no-BS, data-driven column on the New York Times’ Upshot site, highlights several reasons why you should take this new sugar study with a grain of salt.

Did the participants differ by race or ethnicity? I have no idea. I do know, however, that the authors write about the “absence of ethnic minorities, which limits the generalizability of our findings to populations of non-European decent.” Was that in the coverage you read?

Did they differ by socioeconomic status? No idea. Did they abuse drugs? Work or retire? Live alone or with someone? Have a family history of disease? No idea.

Did they acknowledge that different artificial sweeteners are different molecules with likely different effects or implications? No.

Were there multiple comparisons, meaning some results might be due to chance? Yep. Did they rely on self-report, which might mean recall bias comes into play? Yep.

Was this an observational study? Of course.

Was all of that in the coverage you read?

Carroll’s explanation is a lot more in-depth than that, digging into nerdy-but-important factors like the actual models the study’s authors used, the limitations they openly admitted to, and information we simply don’t know about their analysis.

But this does reflect a common theme in mainstream media science reporting. The drive to report the most provocative (in many cases, concerning) headlines obscure the incremental, nuanced, and decidedly not-reductive nature of good science. If you were to rely on flashy media headlines alone, you might think that everything causes cancer—or prevents it!

None of this is to say that sugar alternatives don’t come with health risks; they very well might. But limited, observational studies about public health trends can only take you so far down the path to real knowledge. So don’t feel pressured to freak out about that diet drink because the Internet told you to.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Most Popular

placeholder alt text
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By Emma BurleighFebruary 2, 2026
2 days ago
placeholder alt text
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
By Eleanor PringleFebruary 4, 2026
11 hours ago
placeholder alt text
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the board
By Jim EdwardsFebruary 4, 2026
15 hours ago
placeholder alt text
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’
By Eva RoytburgFebruary 2, 2026
2 days ago
placeholder alt text
North America
Gates Foundation doubles down on foreign aid as U.S. government largely withdraws
By Thalia Beaty and The Associated PressFebruary 3, 2026
2 days ago
placeholder alt text
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with Trump
By Tristan BoveFebruary 3, 2026
1 day ago

Latest in Health

HealthDietary Supplements
The 6 Best Prebiotics of 2026: Tester Approved
By Christina SnyderFebruary 4, 2026
4 hours ago
Healthsleep
The Best Cooling Sheets of 2026: Personally Tested
By Christina SnyderFebruary 4, 2026
4 hours ago
A person sleeping in bed.
Healthsleep
What Is the Best Sleeping Position?
By Jessica RendallFebruary 4, 2026
9 hours ago
C-Suitesubscription economy
The CEO of $11 billion Oura explains why customers must shell out for subscription fees after paying $349 or more for the ring
By Marco Quiroz-GutierrezFebruary 4, 2026
9 hours ago
Healthsleep
7 Best Mattresses for Stomach Sleepers of 2026: Sleep Expert Tested
By Christina SnyderFebruary 4, 2026
12 hours ago
SuccessOlympics
U.S. Olympians earn just 5% of what Singapore pays—many are forced to juggle jobs as baristas, brokers, and dentists just to get by
By Sydney LakeFebruary 3, 2026
1 day ago